We are fortunate to advise world-class, industry-leading companies, helping them tackle novel, complex issues and push the boundaries of technological progress. Our ability and confidence to go to trial is our core strength; our deep bench of experienced trial lawyers represents companies in their most significant matters, helping them protect their intellectual property and launch products. Our lawyers pair extensive experience in the courtroom and the boardroom with a thorough understanding of science and technology.
Intellectual Property Litigation: 'Myriad' of Unanswered Questions Remain
August 12, 2013 Read the article
Litigation partner Lewis Clayton's Intellectual Property Litigation column appeared in the August 12 issue of The National Law Journal. The article, "'Myriad' of Unanswered Questions Remain," reviews the U.S. Supreme Court decision in Association for Molecular Pathology v. Myriad Genetics, which considered whether portions of human genes may be patented.